Torres, D.G.; Paes, J.; da Costa, A.G.; Malheiro, A.; Silva, G.V.; Mourão, L.P.d.S.; Tarragô, A.M.
JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms. Biomolecules 2022, 12, 291.
https://doi.org/10.3390/biom12020291
AMA Style
Torres DG, Paes J, da Costa AG, Malheiro A, Silva GV, Mourão LPdS, Tarragô AM.
JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms. Biomolecules. 2022; 12(2):291.
https://doi.org/10.3390/biom12020291
Chicago/Turabian Style
Torres, Dania G., Jhemerson Paes, Allyson G. da Costa, Adriana Malheiro, George V. Silva, Lucivana P. de Souza Mourão, and Andréa M. Tarragô.
2022. "JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms" Biomolecules 12, no. 2: 291.
https://doi.org/10.3390/biom12020291
APA Style
Torres, D. G., Paes, J., da Costa, A. G., Malheiro, A., Silva, G. V., Mourão, L. P. d. S., & Tarragô, A. M.
(2022). JAK2 Variant Signaling: Genetic, Hematologic and Immune Implication in Chronic Myeloproliferative Neoplasms. Biomolecules, 12(2), 291.
https://doi.org/10.3390/biom12020291